Glucocerebrosidase (GBA) heterozygous variants are the most important genetic risk factor for the development of Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB) (i.e., alpha-synucleinopathies) [1]. This evidence concerns the gene GBA1 and Lewy body dementia.